BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 16952555)

  • 1. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.
    Fukata M; Chen A; Klepper A; Krishnareddy S; Vamadevan AS; Thomas LS; Xu R; Inoue H; Arditi M; Dannenberg AJ; Abreu MT
    Gastroenterology; 2006 Sep; 131(3):862-77. PubMed ID: 16952555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid.
    Zheng L; Riehl TE; Stenson WF
    Gastroenterology; 2009 Dec; 137(6):2041-51. PubMed ID: 19732774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
    Fei L; Xu K
    J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of toll-like receptor 4 (TLR4) in dextran sulfate sodium (DSS)-Induced intestinal injury and repair.
    Shi YJ; Gong HF; Zhao QQ; Liu XS; Liu C; Wang H
    Toxicol Lett; 2019 Oct; 315():23-30. PubMed ID: 31442584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut.
    Ortega-Cava CF; Ishihara S; Rumi MA; Kawashima K; Ishimura N; Kazumori H; Udagawa J; Kadowaki Y; Kinoshita Y
    J Immunol; 2003 Apr; 170(8):3977-85. PubMed ID: 12682225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.
    Cario E; Gerken G; Podolsky DK
    Gastroenterology; 2007 Apr; 132(4):1359-74. PubMed ID: 17408640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.
    Hernandez Y; Sotolongo J; Breglio K; Conduah D; Chen A; Xu R; Hsu D; Ungaro R; Hayes LA; Pastorini C; Abreu MT; Fukata M
    BMC Gastroenterol; 2010 Jul; 10():82. PubMed ID: 20637112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
    Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
    J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice.
    Dong L; Li J; Liu Y; Yue W; Luo X
    J Gastroenterol Hepatol; 2012 Jan; 27(1):110-9. PubMed ID: 21722182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.
    Fukata M; Michelsen KS; Eri R; Thomas LS; Hu B; Lukasek K; Nast CC; Lechago J; Xu R; Naiki Y; Soliman A; Arditi M; Abreu MT
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1055-65. PubMed ID: 15826931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.
    Ungaro R; Fukata M; Hsu D; Hernandez Y; Breglio K; Chen A; Xu R; Sotolongo J; Espana C; Zaias J; Elson G; Mayer L; Kosco-Vilbois M; Abreu MT
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1167-79. PubMed ID: 19359427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine alleviates intestinal barrier dysfunction and inflammatory response in mice via suppressing TLR4/MyD88/NF-κB signaling in an experimental model of ulcerative colitis.
    Ye X; Xu H; Xu Y
    Folia Histochem Cytobiol; 2022; 60(4):311-322. PubMed ID: 36504132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
    Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
    World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.
    Fukata M; Hernandez Y; Conduah D; Cohen J; Chen A; Breglio K; Goo T; Hsu D; Xu R; Abreu MT
    Inflamm Bowel Dis; 2009 Jul; 15(7):997-1006. PubMed ID: 19229991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis.
    Hoffman JM; Baritaki S; Ruiz JJ; Sideri A; Pothoulakis C
    Am J Pathol; 2016 Jan; 186(1):134-44. PubMed ID: 26597886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.
    Fukata M; Shang L; Santaolalla R; Sotolongo J; Pastorini C; España C; Ungaro R; Harpaz N; Cooper HS; Elson G; Kosco-Vilbois M; Zaias J; Perez MT; Mayer L; Vamadevan AS; Lira SA; Abreu MT
    Inflamm Bowel Dis; 2011 Jul; 17(7):1464-73. PubMed ID: 21674704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxO1 regulates TLR4/MyD88/MD2-NF-κB inflammatory signalling in mucosal barrier injury of inflammatory bowel disease.
    Han C; Guo L; Sheng Y; Yang Y; Wang J; Gu Y; Li W; Zhou X; Jiao Q
    J Cell Mol Med; 2020 Mar; 24(6):3712-3723. PubMed ID: 32057181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
    Yang Y; Sheng Y; Wang J; Zhou X; Guan Q; Shen H; Li W; Ruan S
    J Cell Mol Med; 2021 Aug; 25(15):7257-7269. PubMed ID: 34184406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.